Control of Myopia Using Novel Spectacle Lens Designs
NCT: NCT03623074 · ACTIVE_NOT_RECRUITING
Publicidade
Resumo breve
Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens design in reducing the progression of juvenile myopia.
Fonte oficial
Ver no ClinicalTrials.gov →Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.